兒童疫苗市場規模、佔有率和成長分析：按疫苗類型、技術、疾病適應症、最終用戶、銷售管道和地區分類－產業預測，2026-2033年

2024 年全球兒童疫苗市場價值為 232.5 億美元，預計到 2033 年將從 2025 年的 246 億美元成長到 386.2 億美元，預測期（2026-2033 年）的複合年成長率為 5.8%。

兒童疫苗市場從根本上受到公共衛生政策和資金籌措的影響，這些政策和資金決定了免疫接種計劃和全球採購，進而影響研究方向和供應。針對麻疹和脊髓灰質炎等疾病的疫苗對於降低兒童死亡率和住院率至關重要，並顯著促進了經濟穩定。在諸如全球疫苗免疫聯盟（Gavi）和聯合國兒童基金會（UNICEF）等組織的支持下，該領域已從早期的根除疾病努力發展到如今先進的結合疫苗和混合疫苗，從而改善了低收入國家的疫苗可及性。監管協調和對新配方日益成長的需求推動了創新，進而促進了市場成長；技術進步使得疫苗能夠以更少的劑量提供更廣泛的保護。此外，人工智慧透過最佳化抗原設計、臨床試驗計畫和試驗點選擇，提高了疫苗研發效率，加速了安全有效的兒童疫苗的開發。

全球兒童疫苗市場促進因素

全球兒童疫苗市場的成長主要得益於各國政府機構和世界衛生組織擴大兒童免疫接種舉措。這有助於疫苗的常規採購，並帶動市場需求的成長。將新型兒童疫苗納入國家免疫規劃，有助於建立可靠的長期採購協議，從而鼓勵生產者提升產能並改善供應鏈流程。此外，政策的日益重視也促使採購體係得到完善，分銷網路得到加強，並最終擴大了疫苗的覆蓋範圍。這些因素共同創造了一個穩定的商業環境，有利於研發和推出符合公共衛生需求的創新兒童疫苗製劑。

全球兒童疫苗市場面臨的限制因素

全球兒童疫苗市場面臨許多挑戰，阻礙了市場擴張，尤其是在資源匱乏地區，這主要是由於各種疫苗對低溫運輸的要求嚴格而複雜。儲存和運輸過程中嚴格的溫度控制要求增加了物流難度，並提高了疫苗劣化的風險。這種情況導致醫療系統採取更謹慎的採購方式，對偏遠和醫療資源匱乏地區的疫苗供應造成了負面影響。因此，整體疫苗接種率正在下降，製藥公司也不願開發或擴大需要嚴格處理的新配方疫苗的生產。因此，持續存在的基礎設施和物流挑戰是導致市場成長緩慢的原因之一。

全球兒童疫苗市場趨勢

全球兒童疫苗市場正經歷著向耐熱疫苗創新的重大轉變，這將徹底改變資源匱乏和偏遠地區的免疫策略。製造商正優先開發耐熱配方和替代給藥系統，以在無需嚴格冷藏的情況下保持疫苗效力。隨著疫苗保存期限穩定性在籌資策略中變得日益重要，這一趨勢擴大了疫苗的供應範圍並減少了浪費。隨著法律規範適應這些進步，研發人員和配方專家之間的合作正在加強以整體擁有成本 (TCO) 為中心的商業策略。這將最終增強全面的免疫接種工作，同時最大限度地減少對低溫運輸基礎設施的依賴。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球兒童疫苗市場規模：依疫苗類型分類

• 疫苗單價
• 多價疫苗
• 其他

全球兒童疫苗市場規模：依技術領域分類

• 活病毒疫苗
• 去活化疫苗
• 類毒素疫苗
• 結合疫苗
• mRNA平台
• DNA平台
• 其他

全球兒童疫苗市場規模：依疾病適應症分類

• 感染疾病
  • 脊髓灰質炎
  • 麻疹
  • 肝炎
• 過敏
• 癌症
• 其他

全球兒童疫苗市場規模：依最終用戶分類

• 政府免疫計劃
• 小兒科診所
• 私人醫療中心
• 社區健康中心
• 其他

全球兒童疫苗市場規模：依銷售管道分類

• 公共採購競標
• 藥品批發商
• 其他

全球兒童疫苗市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• GlaxoSmithKline（GSK）
• Merck & Co.
• Pfizer
• Sanofi
• Serum Institute of India
• Mitsubishi Tanabe Pharma
• Takeda
• Panacea Biotec
• Bio-Med
• Sinovac Biotech
• Haffkine Bio-Pharmaceutical
• Biological E
• Daiichi Sankyo
• Emergent BioSolutions
• Valneva
• Bharat Biotech
• Meiji Holdings
• Indian Immunologicals
• Zydus Lifesciences
• CSL Limited

結論與建議

Global Pediatric Vaccines Market size was valued at USD 23.25 Billion in 2024 and is poised to grow from USD 24.6 Billion in 2025 to USD 38.62 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The pediatric vaccines market is fundamentally shaped by public health policies and funding, which govern immunization schedules and global procurement, influencing both research directions and supply volumes. Vaccines targeting diseases like measles and polio are vital for reducing mortality and hospitalizations among children, contributing significantly to economic stability. The sector has progressed from historical eradication efforts to advanced conjugate and combination products, aided by organizations like Gavi and UNICEF to enhance access in low-income nations. Innovations driven by regulatory harmonization and heightened demand for new formulations facilitate growth, with technology allowing for broader protection through fewer doses. Moreover, AI enhances vaccine development efficiency by optimizing antigen design, trial planning, and site selection, thus expediting safe and effective pediatric vaccines.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pediatric Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pediatric Vaccines Market Segments Analysis

Global pediatric vaccines market is segmented by vaccine type, technology focus, disease indication, end-user, sales channel and region. Based on vaccine type, the market is segmented into Monovalent Vaccines, Multivalent Vaccines and Others. Based on technology focus, the market is segmented into Live Attenuated, Inactivated, Toxoid, Conjugate Vaccines, mRNA Platforms, DNA Platforms and Others. Based on disease indication, the market is segmented into Infectious Diseases, Allergies, Cancer and Others. Based on end-user, the market is segmented into Government Immunization Programs, Pediatric Clinics, Private Healthcare Centers, Community Health Centers and Others. Based on sales channel, the market is segmented into Public Procurement Tenders, Pharmaceutical Distributors and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pediatric Vaccines Market

The growth of the Global Pediatric Vaccines market is significantly driven by the expansion of childhood immunization initiatives by government bodies and international health organizations, which boosts routine vaccine procurement and fosters increased market demand. The incorporation of new pediatric vaccines into national immunization schedules establishes reliable long-term purchasing commitments that encourage manufacturers to enhance their production capabilities and refine supply chain processes. Additionally, a heightened policy emphasis improves procurement systems and strengthens distribution networks, ultimately extending geographic access. Together, these elements cultivate a stable commercial landscape that promotes the research, development, and launch of innovative pediatric vaccine formulations aligned with public health needs.

Restraints in the Global Pediatric Vaccines Market

The Global Pediatric Vaccines market faces significant challenges due to the stringent and intricate cold chain requirements for various vaccines, which hinder expansion efforts, especially in under-resourced areas. The necessity for strict temperature control during storage and transportation complicates logistics and elevates the risk of spoilage. This situation leads to a more cautious procurement approach by health systems, adversely affecting vaccine availability in remote and underserved regions. As a result, overall vaccination uptake is diminished, discouraging pharmaceutical companies from increasing production or developing new formulations that demand rigorous handling. Thus, persistent infrastructure and logistical issues contribute to the market's sluggish growth.

Market Trends of the Global Pediatric Vaccines Market

The Global Pediatric Vaccines market is experiencing a significant shift towards thermostable vaccine innovations, which are revolutionizing immunization strategies in resource-limited and remote regions. Manufacturers are prioritizing the development of heat-stable formulations and alternative delivery systems that maintain vaccine efficacy without stringent refrigeration requirements. This trend facilitates extended access and reduces vaccine wastage, as procurement strategies increasingly emphasize resilience in shelf-life. As regulatory frameworks adapt to accommodate these advancements, collaborations between developers and formulation specialists are enhancing commercial strategies centered on total cost of ownership, ultimately bolstering comprehensive immunization efforts while minimizing reliance on cold-chain infrastructure.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pediatric Vaccines Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Monovalent Vaccines
• Multivalent Vaccines
• Others

Global Pediatric Vaccines Market Size by Technology Focus & CAGR (2026-2033)

• Market Overview
• Live Attenuated
• Inactivated
• Toxoid
• Conjugate Vaccines
• mRNA Platforms
• DNA Platforms
• Others

Global Pediatric Vaccines Market Size by Disease Indication & CAGR (2026-2033)

• Market Overview
• Infectious Diseases
  • Polio
  • Measles
  • Hepatitis
• Allergies
• Cancer
• Others

Global Pediatric Vaccines Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Government Immunization Programs
• Pediatric Clinics
• Private Healthcare Centers
• Community Health Centers
• Others

Global Pediatric Vaccines Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Public Procurement Tenders
• Pharmaceutical Distributors
• Others

Global Pediatric Vaccines Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Technology Focus, Disease Indication, End-User, Sales Channel)
  • US
  • Canada
• Europe (Vaccine Type, Technology Focus, Disease Indication, End-User, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Technology Focus, Disease Indication, End-User, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Technology Focus, Disease Indication, End-User, Sales Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Technology Focus, Disease Indication, End-User, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GlaxoSmithKline (GSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panacea Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Med
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinovac Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haffkine Bio-Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological E
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meiji Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations